Regen BioPharma Inc (RGBP)

[cvinvestor]

Now that we have a PR somewhat addressing a time frame for NR2F6 small molecule development (goal of 3rd-4th Qtr 2017 clinical trials), it would be nice to get a PR that updates us as to the plans, if any, for HemaXellerate and dCellVax, one which is ready and waiting for almost a year for human trials to be started by company and the other, submitted and awaiting FDA clearance for human trials.

We need to know if the FDA clears dCellVax for human trials, do they plan on taking any action to proceed or is it going to be shelved because all money and effort is now on the longer term NR2F6?